Follow
Val M. Runge
Title
Cited by
Cited by
Year
Hepatic MR imaging with ferumoxides: a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions.
PR Ros, PC Freeny, SE Harms, SE Seltzer, PL Davis, TW Chan, ...
Radiology 196 (2), 481-488, 1995
3891995
Safety of approved MR contrast media for intravenous injection
VM Runge
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2000
3492000
MRI contrast agents: basic chemistry and safety
D Hao, T Ai, F Goerner, X Hu, VM Runge, M Tweedle
Journal of Magnetic Resonance Imaging 36 (5), 1060-1071, 2012
3422012
MR imaging of tumor microcirculation: promise for the new millenium
JS Taylor, PS Tofts, R Port, JL Evelhoch, M Knopp, WE Reddick, ...
Journal of Magnetic Resonance Imaging: An Official Journal of the …, 1999
2841999
Initial clinical experience with dextran-coated superparamagnetic iron oxide for detection of lymph node metastases in patients with head and neck cancer.
Y Anzai, KE Blackwell, SL Hirschowitz, JW Rogers, Y Sato, WT Yuh, ...
Radiology 192 (3), 709-715, 1994
2721994
T1 relaxivities of gadolinium-based magnetic resonance contrast agents in human whole blood at 1.5, 3, and 7 T
Y Shen, FL Goerner, C Snyder, JN Morelli, D Hao, D Hu, X Li, VM Runge
Investigative radiology 50 (5), 330-338, 2015
2612015
Nephrogenic systemic fibrosis: a review of 6 cases temporally related to gadodiamide injection (Omniscan)
A Khurana, VM Runge, M Narayanan, JF Greene Jr, AE Nickel
Investigative radiology 42 (2), 139-145, 2007
2412007
Contrast agents for magnetic resonance imaging: safety update
MA Kirchin, VM Runge
Topics in Magnetic Resonance Imaging 14 (5), 426-435, 2003
2172003
Paramagnetic agents for contrast-enhanced NMR imaging: a review
VM Runge, JA Clanton, CM Lukehart, CL Partain, AE James Jr
American journal of roentgenology 141 (6), 1209-1215, 1983
2131983
Respiratory gating in magnetic resonance imaging at 0.5 Tesla.
VM Runge, JA Clanton, CL Partain, AE James Jr
Radiology 151 (2), 521-523, 1984
2031984
An image-based approach to understanding the physics of MR artifacts
JN Morelli, VM Runge, F Ai, U Attenberger, L Vu, SH Schmeets, WR Nitz, ...
Radiographics 31 (3), 849-866, 2011
1832011
Critical questions regarding gadolinium deposition in the brain and body after injections of the gadolinium-based contrast agents, safety, and clinical recommendations in …
VM Runge
Investigative radiology 52 (6), 317-323, 2017
1772017
Safety of the gadolinium-based contrast agents for magnetic resonance imaging, focusing in part on their accumulation in the brain and especially the dentate nucleus
VM Runge
Investigative radiology 51 (5), 273-279, 2016
1582016
Work in progress: potential oral and intravenous paramagnetic NMR contrast agents.
VM Runge, RG Stewart, JA Clanton, MM Jones, CM Lukehart, CL Partain, ...
Radiology 147 (3), 789-791, 1983
1581983
Particulate NMR contrast agents for gastrointestinal application
VM Runge, JA Clanton
US Patent 4,615,879, 1986
1511986
Hepatic metastases and cavernous hemangiomas: distinction with standard-and triple-dose gadoteridol-enhanced MR imaging.
DG Mitchell, S Saini, J Weinreb, EE De Lange, VM Runge, JE Kuhlman, ...
Radiology 193 (1), 49-57, 1994
1451994
Magnetic resonance imaging of multiple sclerosis: a study of pulse-technique efficacy
VM Runge, AC Price, HS Kirshner, JH Allen, CL Partain, AE James Jr
American journal of roentgenology 143 (5), 1015-1026, 1984
1391984
Safety of magnetic resonance contrast media
VM Runge
Topics in Magnetic Resonance Imaging 12 (4), 309-314, 2001
1332001
Phase III multicenter trial of high-dose gadoteridol in MR evaluation of brain metastases.
WT Yuh, DJ Fisher, VM Runge, SW Atlas, SE Harms, KR Maravilla, ...
American journal of neuroradiology 15 (6), 1037-1051, 1994
1241994
High‐dose gadoteridol in MR imaging of intracranial neoplasms
VM Runge, JE Kirsch, VJ Burke, AC Price, KL Nelson, GS Thomas, ...
Journal of Magnetic Resonance Imaging 2 (1), 9-18, 1992
1211992
The system can't perform the operation now. Try again later.
Articles 1–20